MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cancer vaccines'. Sat, 03 Sep 2011 02:40:36 +0100 http://www.medworm.com/index.php?rid=2851734&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FDtNmPZrEDh8%2F An apparently healthy teenage girl gets a cervical cancer vaccine, and drops dead a few hours later. Did the vaccine cause the death? Not in the U.K. case we mentioned earlier this week. An autopsy found that Natalie Morton died of a previously undiagnosed tumor in her chest, the BBC reports. That sad case is a reminder to be wary of confusing proximity in time with cause and effect — a concept public-health officials have been citing in advance of the imminent roll out of the swine (H1N1) flu vaccine. As the CDC chief recently pointed out, there will be people who get a swine flu shot and suddenly drop dead a few hours later. Pregnant women will get the vaccine and go on to have miscarriages. In those situations, he said, “we need to know very clearly how many we would expec... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2851734 Thu, 01 Oct 2009 14:58:58 +0100 2851734 http://www.medworm.com/index.php?rid=2375877&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FB_LSgS-sFzs%2F Shares of biotech company Dendreon plummeted today as the company was getting ready for its long-awaited moment in the sun reporting positive results for its prostate cancer treatment Provenge. After moving higher for much of the day and hitting a new 52-week high of $25 a share, the Seattle company’s stock plunged 45% just before trading was halted for news. The shares fell more than $10 in about 30 seconds of vigorous trading, Thomas Gryta of Dow Jones Newswires reported. The Nasdaq Stock Market initially said on its Web site that it was investigating “potentially erroneous” trades in Dendreon shares between 1:25 p.m. and 1:27 p.m. EDT. Nasdaq later said the trades would stand. After all that excitement, researchers provided detailed data from a Provenge study called Impact. The stud... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2375877 Tue, 28 Apr 2009 20:09:01 +0100 2375877 http://www.medworm.com/index.php?rid=1886858&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FY2iZ0jYOzts%2F Baltimore Sun photo by Chiaki Kawajiri Annie Siple jokes with her husband, Cory, in Mineola, Fla. She traveled monthly to Johns Hopkins for a vaccine trial. We couldn’t let the week end without drawing your attention to the Baltimore Sun’s six-part series on the work of Leisha Emens, a Johns Hopkins oncologist who is trying to come up with a vaccine to treat breast cancer. The last of the stories appeared today, but you should probably start at the beginning if you’re just finding out about this. The Sun describes Emens’s quest for a vaccine to mobilize T cells in the body’s immune system to kill cancer cells. Her efforts, stretching back almost 20 years, now involve testing a combination of an experimental vaccine and low doses of cancer drugs. More than ... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1886858 Sat, 18 Oct 2008 13:05:39 +0100 1886858 http://www.medworm.com/index.php?rid=1856594&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FH61IQjzr7Dk%2F Dendreon is back. The beleaguered biotech reported that its prostate cancer vaccine Provenge cut the risk of death by 20% compared with a placebo in a clinical test. As nearly every other stock (other than ImClone Systems) got hammered today, Dendreon shares soared $2.41, or 47%, to $7.61 in early afternoon trading. The update came from an interim analysis of a study that was good, but not good enough to lead to an immediate request for the FDA to approve the treatment, Dow Jones Newswires reported. For one thing, Dendreon doesn’t know many details of the results for the vaccine because the trial remains blinded. Still, Dendreon’s data appear encouraging. The study, designed to measure overall survival, is expected to stop once 304 patients have died, which is likely to occur ... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1856594 Tue, 07 Oct 2008 15:09:49 +0100 1856594 http://www.medworm.com/index.php?rid=1856097&cid=t_193876_131_f&fid=34989&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2FUjvg0Yg14mw%2F It’s already been done with cervical cancer, so why not develop a vaccine for breast cancer? That’s the challenge that Professor Valerie Beral of Oxford University asks the scientific community. The lead scientist in the Million Women’s Study says that the causes of breast cancer have been so well studied that a vaccine or a prophylactic drug is should be a real possibility. Speaking to the UK Guardian, Beral suggested that genes played a part in only a small number of breast cancer. Instead, it’s the processes of birth and breastfeeding that protect a woman from breast cancer more than anything else. It’s interesting that the short-term exposure during late pregnancy and prolonged breastfeeding were postulated to have protective effects against breast cancer ... Genetics and Health blogs http://www.medworm.com/rss/comments.php?id=1856097 Tue, 07 Oct 2008 07:42:26 +0100 1856097 http://www.medworm.com/index.php?rid=1461356&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F295908509%2F Listeria is a nasty bacterium that’s a rather common cause of food-borne illness, especially in pregnant women and immuno-compromised patients. But some researchers are trying to turn the pathogen into a messenger that compels the body to attack cancer and other diseases, Scientific American reports. Advaxis, a New Jersey biotech shop, said this week it’s moving into mid-stage trials of a Listeria-based vaccine to treat a condition that precedes cervical cancer. It’s still early days yet for the treatment, which remains unproved. But the notion is pretty interesting. Because humans have been living with Listeria for a long, long time, we’ve evolved a strong immune response to the bacterium. That makes the bug a promising candidate for disease treatments that aim to... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1461356 Thu, 22 May 2008 16:28:56 +0100 1461356 http://www.medworm.com/index.php?rid=1098948&cid=t_193876_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F201650198%2F Merck CEO Richard Clark just got another reason for his FDA fandom. The FDA has more questions about GlaxoSmithKline’s cervical cancer vaccine Cervarix and that gives Merck’s Gardasil more time as the only one on the U.S. market. Merck’s enjoyed a string of FDA approvals, unlike some rivals, and Clark defended the agency in an interview with the Health Blog last week. He says executives shouldn’t blame their problems on FDA being slow to greenlight new medicines. Glaxo says the vaccine has been approved in 45 countries, but it still needs to be working “diligently to resolve any outstanding questions to bring Cervarix to the U.S.market.” Novartis, Merck’s would-be rival for a new way to treat diabetes, has had trouble getting traction with Galvus... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1098948 Mon, 17 Dec 2007 15:17:03 +0100 1098948 http://www.medworm.com/index.php?rid=1129424&cid=t_193876_136_f&fid=35294&url=http%3A%2F%2Fpsa-rising.com%2Fblog%2Findex.php%2F2007%2F08%2F18%2Fneuvenge-breast-cancer-vaccine-phase-1-results Results from a Phase 1 study of NEUVENGE, Dendreon’s candidate vaccine for breast cancer, appeared today in Journal of Clinical Oncology. Testing of Neuvenge in clinical trials runs several years behind Provenge, which is in an ongoing Phase 3 trial. Out of 18 patients with advanced breast cancer who received Neuvenge, 1 patient showed [...] (Source: psa-rising.com/blog) psa-rising.com/blog blogs http://www.medworm.com/rss/comments.php?id=1129424 Sat, 18 Aug 2007 07:11:18 +0100 1129424 http://www.medworm.com/index.php?rid=523242&cid=t_193876_87_f&fid=35057&url=http%3A%2F%2Fblogs.orlandosentinel.com%2Ffeatures_healthblog%2F2007%2F04%2Fdebate_rages_ov.html The new vaccine against HPV - shown left - remains a hot topic. The shot protects against the human papillomavirus (HPV), which can be spread through sexual contact and lead to cervical cancer or genital warts. The political controversy centers... (Source: Health Check the Blog) Health Check the Blog blogs http://www.medworm.com/rss/comments.php?id=523242 Thu, 05 Apr 2007 10:41:00 +0100 523242